Amcor plc (AMCR) Market Cap & Valuation Ratios
Amcor plc (AMCR) has a market cap of $21.3B, a trailing P/E of 24.0 and a price-to-sales ratio of 0.9, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AMCRAmcor plcFollow AMCR — free
—
Price chart with a free account
- Market cap
- 21.3B
- P/E TTM
- 24.0
- Dividend yield
- 5.6%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Peers
packaging & containers · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| AMCR | 21 | 24.0 | 1.5 | 10.1 | 5.8% | +57% | 8% | 7% |
| PKG | 22 | 32.1 | 2.7 | 14.0 | 3.4% | +10% | 11% | 11% |
| SW | 22 | 44.1 | 1.1 | 8.4 | 4.6% | +2% | 5% | 3% |
| IP | 18 | — | 1.1 | 317.9 | 2.8% | +25% | -11% | -11% |
| BALL | 17 | 18.4 | 1.7 | 11.2 | 4.8% | +16% | 10% | 10% |
| AVY | 14 | 19.9 | 1.9 | 11.9 | 7.7% | +6% | 12% | 14% |
| CCK | 13 | 16.9 | 1.4 | 8.7 | 9.4% | +10% | 12% | 14% |
| GEF-B | 5.2 | — | 1.5 | 9.6 | -4.3% | -9% | 10% | 8% |
| SON | 5.0 | 8.0 | 1.2 | 5.9 | 7.2% | +18% | 14% | 10% |
| REYN | 4.9 | 14.0 | 1.7 | 9.4 | 6.6% | +3% | 14% | 11% |
| SLGN | 4.2 | 15.4 | 1.3 | 9.5 | 8.3% | +8% | 9% | 6% |
| Median of these 10 | 17.6 | 1.4 | 9.6 | 5.7% | +9% | 11% | 10% |
P/E 24.0 vs. a peer median of 17.6; EV/Sales 1.5 vs. 1.4. AMCR's own P/E sits at the 23rd percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesIP and GEF-B have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Amcor plc — questions
- What is Amcor plc's market cap?
- $21.3B.
- What is Amcor plc's P/E ratio?
- 24.0 on trailing twelve-month earnings to 2026-06-30.
- What is Amcor plc's price-to-sales ratio?
- 0.9.
Every figure on this page comes from Amcor plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.